Xenon Pharmaceuticals Inc. has announced positive topline results from the Phase 3 X-TOLE2 study of azetukalner, a novel KV7 potassium channel opener, in treating focal onset seizures. This milestone underscores the company’s commitment to advancing life-changing therapeutics for patients with epilepsy and depression.

Tired of dealing with bulky hoses and endless scrubbing? The Talosbo C1 Cordless Robotic Pool Cleaner promises to automate the most demanding aspects of pool maintenance, delivering a clearer, more inviting swimming area without the usual hassles.

Emergency responders say they’re becoming “unpaid roadside assistance” for Waymo’s self-driving vehicles. As these autonomous cars occasionally freeze or stall, the police and fire crews are left covering gaps in technology, prompting calls for more accountability from the companies behind them.

Claritas iPET™ has been approved by the Australian Therapeutic Goods Administration, enabling hospitals to produce sharper and clearer PET scans. This regulatory green light may allow for shorter scan times or reductions in radiation dosage, improving patient care and comfort.

Apples float gently through water channels and roll under high-speed cameras, illustrating a seamless blend of tradition and technology. At Columbia Fruit Packers, the orchard-to-market journey unfolds in a cool, metallic environment where innovation meets the natural magic of fresh produce.

A new startup is using artificial intelligence to craft personalized notes for your friends and family, and then having them written out by a robot pen. In an era where inboxes are overflowing, they’re betting on physical letters to stand out from the digital noise.

Tri-County’s latest initiative offers $2,000 scholarships to students pursuing AI or robotics programs this fall. This opportunity reflects a growing commitment to advanced technology and highlights how regional collaboration can shape the future of work.

Seneca’s groundbreaking, five-year partnership with Aspen Fire Protection District heralds a new era of AI-driven aerial firefighting. Featuring an autonomous squadron capable of dropping nearly 500 gallons of foam per sortie, this deal promises to bolster community resilience and elevate firefighter safety across Aspen’s wildland–urban interface.

A new agricultural venture is harnessing engineering and entrepreneurial prowess to reshape how farms use fertilizer. Through advanced solutions, Reform Bio aims to curb nutrient leaching and water runoff, paving the way for more sustainable farming.

Stanford Medicine researchers have conducted a groundbreaking study indicating that a single vaccine can protect mice from a range of infections. By targeting respiratory viruses, bacteria, and even allergens, this approach offers a potential new pathway for disease prevention.

Toyota is taking a bold step by introducing humanoid robots at its Canadian assembly plant. While the full details remain behind a paywall, the move reflects a new phase of automation in automotive manufacturing.

Medline’s newly upgraded Relative Strength Rating offers a glimpse into its rising technical performance in the biotech and pharma space. With an 81 RS Rating, the company demonstrates improving market leadership in a competitive industry.

A strategic partnership has propelled West Chester-based Verrica Pharmaceuticals into the Japanese market, as Torii Pharmaceutical Co. Ltd. launches YCANTH for molluscum contagiosum. The approval, granted in September 2025, marks an important step in offering treatment options to patients suffering from this skin condition.

Apptronik, an AI-powered robotics company, announced a new $520 million extension round, propelling its total Series A to over $935 million. This significant investment underscores strong investor confidence in the development of the company’s humanoid robot, ApolloTM, and its vision for large-scale deployment worldwide.

Alvotech has entered key supply and commercialization agreements with Sandoz to expand biosimilar treatments in Canada and across Australia and New Zealand. The deal covers multiple therapeutic areas—ophthalmology, immunology, and gastroenterology—and positions both companies to broaden patient access through shared responsibilities in development, manufacturing, and distribution.

Two California car makers—one large, one small—recently announced their intent to expand from electric vehicles into the realm of robotics. This strategic pivot underscores both companies’ drive to innovate beyond traditional automotive manufacturing.

Pony.ai has announced a strategic partnership with Beijing ATBB Travel & Express Service Co., Ltd., geared toward expanding robotaxi services across both urban and airport settings. This move underscores Pony.ai’s leadership in large-scale mass production and commercialization of autonomous driving technology.

The global clinical mass spectrometry market is expected to reach USD 3.31 billion by 2031, signaling a profound shift toward high-specificity diagnostics. Recent findings highlight this technology’s growing influence on clinical labs worldwide, positioning it for substantial expansion.

MIT’s Associate Professor Bryan Bryson is uncovering how Myobacterium tuberculosis interacts with our immune systems, in a focus that could reshape TB vaccine strategies. By translating these biological insights into engineering solutions, Bryson hopes to help eliminate a disease that remains a global challenge.

Polymeric biomaterials have become a focal point in medical innovation, offering personalized solutions for implants, scaffolds, and drug delivery. Driven by rising demand for minimally invasive procedures, the market is expected to surpass US$16 billion by 2030, reshaping clinical care worldwide.

Cabaletta Bio is forging ahead with rese-cel, a CAR T cell therapy for autoimmune diseases, targeting a 2027 FDA submission. The Philadelphia-based biotech has mapped out an ambitious 2026 roadmap that underscores its commitment to advancing next-generation treatment options.